Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helga Radner

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
RMD Open|August 6, 2016
Educational needs and preferences of young European clinicians and physician researchers working in the field of rheumatologyChristian Beyer, Sofia Ramiro, Francisca Sivera, et al.
Therapeutic Advances in Musculoskeletal Disease|December 21, 2020
The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective studyAngelika Lackner, Viktoria Tiefenthaler, Jalia Mirzayeva, et al.
Clinical and Experimental Rheumatology|October 17, 2013
Use of data from multiple registries in studying biologic discontinuation: challenges and opportunitiesKazuki Yoshida, Helga Radner, Arthur Kavanaugh, et al.
RMD Open|January 10, 2024
What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experimentRieke Alten, Juan Carlos Nieto-Gonzalez, Peggy Jacques, et al.
Annals of the Rheumatic Diseases|November 30, 2021
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritisElisabeth Simader, Selma Tobudic, Peter Mandl, et al.
IEEE Journal of Biomedical and Health Informatics|September 9, 2024
COTIDIANA Dataset - Smartphone-Collected Data on the Mobility, Finger Dexterity, and Mental Health of People With Rheumatic and Musculoskeletal DiseasesPedro Matias, Ricardo Araujo, Ricardo Graca, et al.
Seminars in Arthritis and Rheumatism|July 26, 2015
Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohortHelga Radner, Kazuki Yoshida, Maria Dahl Mjaavatten, et al.
BMJ Public Health|November 24, 2025
Occupation: a predisposing factor for SARS-CoV-2 infection among hospital employees? A single-centre retrospective cohort study conducted in AustriaMaximilian Egg, Tibor Spath, Sophie Brunner-Ziegler, et al.
The Journal of Rheumatology|November 3, 2015
Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort StudyKazuki Yoshida, Helga Radner, Maria D Mjaavatten, et al.
Annals of the Rheumatic Diseases|March 19, 2022
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort studyPeter Mandl, Selma Tobudic, Helmut Haslacher, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
RMD Open|August 6, 2016
Educational needs and preferences of young European clinicians and physician researchers working in the field of rheumatologyChristian Beyer, Sofia Ramiro, Francisca Sivera, et al.
Therapeutic Advances in Musculoskeletal Disease|December 21, 2020
The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective studyAngelika Lackner, Viktoria Tiefenthaler, Jalia Mirzayeva, et al.
Clinical and Experimental Rheumatology|October 17, 2013
Use of data from multiple registries in studying biologic discontinuation: challenges and opportunitiesKazuki Yoshida, Helga Radner, Arthur Kavanaugh, et al.
RMD Open|January 10, 2024
What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experimentRieke Alten, Juan Carlos Nieto-Gonzalez, Peggy Jacques, et al.
Annals of the Rheumatic Diseases|November 30, 2021
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritisElisabeth Simader, Selma Tobudic, Peter Mandl, et al.
IEEE Journal of Biomedical and Health Informatics|September 9, 2024
COTIDIANA Dataset - Smartphone-Collected Data on the Mobility, Finger Dexterity, and Mental Health of People With Rheumatic and Musculoskeletal DiseasesPedro Matias, Ricardo Araujo, Ricardo Graca, et al.
Seminars in Arthritis and Rheumatism|July 26, 2015
Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohortHelga Radner, Kazuki Yoshida, Maria Dahl Mjaavatten, et al.
BMJ Public Health|November 24, 2025
Occupation: a predisposing factor for SARS-CoV-2 infection among hospital employees? A single-centre retrospective cohort study conducted in AustriaMaximilian Egg, Tibor Spath, Sophie Brunner-Ziegler, et al.
The Journal of Rheumatology|November 3, 2015
Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort StudyKazuki Yoshida, Helga Radner, Maria D Mjaavatten, et al.
Annals of the Rheumatic Diseases|March 19, 2022
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort studyPeter Mandl, Selma Tobudic, Helmut Haslacher, et al.
Pageof 7